# An Evaluation of Proglucamune in the Treatment of Protective Qi Insufficiency

> **NCT03829228** · NA · COMPLETED · sponsor: **USANA Health Sciences** · enrollment: 30 (actual)

## Conditions studied

- Protective Qi Insufficiency

## Interventions

- **DIETARY_SUPPLEMENT:** Proglucamune

## Key facts

- **NCT ID:** NCT03829228
- **Lead sponsor:** USANA Health Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-18
- **Primary completion:** 2018-06-03
- **Final completion:** 2018-06-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03829228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03829228, "An Evaluation of Proglucamune in the Treatment of Protective Qi Insufficiency". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03829228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*